MEGESTROL ACETATE IMPURITY B
HER2+, Low, or Ultralow Advanced/Metastatic Breast Cancer
Sun Yat-sen UniversitySmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the HER2+, Low, or Ultralow Advanced/Metastatic Breast Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Arimidex Ahon Pharmaceutical Co., Ltd. | Phase 4 | BBB |
PROPOFOL Tata Memorial Centre | Phase 4 | BB |
Sevoflurane Tata Memorial Centre | Phase 4 | BB |
Zoladex Ahon Pharmaceutical Co., Ltd. | Phase 3 | BB |
Gtx-006 Peking Union Medical College Hospital | Phase 4 | BB |
View all 22 →
Same molecule, other indications
MEGESTROL ACETATE IMPURITY B is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →